Altintas stressed that The findings should be viewed as hypothesis-generating rather than practice-changing. The study suggests that semaglutide does not appear to increase fracture risk and may potentially reduce it, but randomized prospective studies with bone mineral density, bone turnover markers, and fracture endpoints will be needed before concluding that semaglutide has true bone-protective properties, he told us
Yes, because B12 is mainly found in animal-based foods
Sometimes, adjusting the dose of tirzepatide or switching to a different therapy is necessary
As a conclusion, oral semaglutide has a CV safety profile similar to that of the subcutaneous form, as shown in SUSTAIN-6 trial
Comment Peptides and Ill send you a FREE Peptide Quiz #PeptideTherapy #FDAUpdate #CompoundingPharmacy #PerformanceHealth #LongevityMedicine To view or add a comment, sign in The FDA has released new peptide compounding documents, and the headlines are already moving faster than the facts
doi: 10.1111/apt.2013.37.issue-11 26 LiuNAndoTIshiguroKMaedaOWatanabeOFunasakaKet al